| Professional Services Industry | Industrials Sector | Ms. Minghui Yu CEO | SSE Exchange | CNE1000059K5 ISIN |
| CN Country | 358 Employees | 10 Jun 2026 Last Dividend | - Last Split | - IPO Date |
Shanghai Rendu Biotechnology Co., Ltd. is a pioneer in the field of RNA molecular diagnostics, focusing on the development and promotion of innovative technology and diagnostic solutions. Founded in 2007, the company has established a significant presence in the healthcare industry, primarily based out of Shanghai, China. With an expansive portfolio that tackles a range of health concerns, Shanghai Rendu Biotechnology is dedicated to improving patient outcomes through precise detection and analysis.
Shanghai Rendu Biotechnology Co., Ltd. offers a comprehensive array of products and services across various healthcare sectors: